Pettinga Financial Advisors’s AbbVie ABBV Stock Holding History

Pettinga Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,282	Closed	-$208K	–	102
2022 Q1	$208K	Buy	+1,282	New	+$186K	0.05%	99
2021 Q4	–	Sell	-2,192	Closed	-$236K	–	110
2021 Q3	$236K	Buy	2,192 +174	+9%	+$19.9K	0.06%	98
2021 Q2	$227K	Hold	2,018	–	–	0.06%	98
2021 Q1	$218K	Sell	2,018 -250	-11%	-$26.7K	0.06%	91
2020 Q4	$243K	Buy	+2,268	New	+$218K	0.09%	77
2020 Q3	–	Sell	-2,268	Closed	-$223K	–	84
2020 Q2	$223K	Buy	+2,268	New	+$200K	0.11%	72
2020 Q1	–	Sell	-2,322	Closed	-$206K	–	70
2019 Q4	$206K	Buy	+2,322	New	+$193K	0.11%	82
2019 Q1	–	Sell	-2,422	Closed	-$223K	–	92
2018 Q4	$223K	Buy	+2,422	New	+$213K	0.15%	80

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pettinga Financial Advisors's ABBV Position: Q2 2022 in Review

Pettinga Financial Advisors sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 1,282 shares — an estimated $208K sold.

Pettinga Financial Advisors first reported a position in ABBV in Q4 2018 and held it in 8 quarters. The position peaked at $243K in Q4 2020. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Pettinga Financial Advisors reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
Pettinga Financial Advisors sold 1,282 AbbVie shares in Q2 2022, an estimated $208K.
Pettinga Financial Advisors first reported a position in AbbVie in Q4 2018 and held it in 8 quarters.
Pettinga Financial Advisors's AbbVie position peaked at $243K in Q4 2020.
3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Pettinga Financial Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.